Skip to content
10-Q

Quarterly Report

TAMIR BIOTECHNOLOGY, INC.

0001308411-13-000127

← back to feed
Filed
May 7, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · May 7, 2013 217.36M sh
Stockholders Equity Q2 2012 · Jan 31, 2012 −$6.99M
Stockholders Equity Q2 2012 · Jul 31, 2011 −$8.1M
Current Liabilities Q2 2012 · Jan 31, 2012 $6.74M
Current Liabilities Q2 2012 · Jul 31, 2011 $5.75M
Total Liabilities Q2 2012 · Jan 31, 2012 $7.41M
Total Liabilities Q2 2012 · Jul 31, 2011 $8.62M
Current Assets Q2 2012 · Jan 31, 2012 $358K
Current Assets Q2 2012 · Jul 31, 2011 $399.3K
Total Assets Q2 2012 · Jan 31, 2012 $422.48K
Total Assets Q2 2012 · Jul 31, 2011 $521.51K
Shares Diluted Q2 2012 · Jan 31, 2011 82.19M sh
Shares Diluted Q2 2012 · Jan 31, 2011 82.47M sh
Capex Q2 2012 · Jan 31, 2011 $0
Operating Cash Flow Q2 2012 · Jan 31, 2011 −$107.97K
Cash And Equivalents Q2 2012 · Jan 31, 2011 $710.33K
Cash And Equivalents Q2 2012 · Jul 31, 2010 $321.25K
Eps Diluted Q2 2012 · Jan 31, 2011 −$0.01
Eps Diluted Q2 2012 · Jan 31, 2011 −$0.02
Eps Basic Q2 2012 · Jan 31, 2011 $0.24
Eps Basic Q2 2012 · Jan 31, 2011 $0.05
Sga Expense Q2 2012 · Jan 31, 2011 $283.37K
Sga Expense Q2 2012 · Jan 31, 2011 $693.14K
Rd Expense Q2 2012 · Jan 31, 2011 $424.98K
Rd Expense Q2 2012 · Jan 31, 2011 $644.3K
Net Income Q2 2012 · Jan 31, 2011 $11.3M
Net Income Q2 2012 · Jan 31, 2011 $2.44M
Operating Income Q2 2012 · Jan 31, 2011 −$708.34K
Operating Income Q2 2012 · Jan 31, 2011 −$1.34M